Your Article Summary
See Latest ArticlesInfectious complications of biological therapy
Current Opinion in Rheumatology, 06/15/09
Haroon N et al. - The incidence of infections decreases with time on biologic therapy. Vaccination is effective while on biological agents, although live vaccines should be avoided. Biologic therapy in the setting of HIV, HCV and HBV continues to be studied, but data are accumulating in support of a favorable safety profile. There are degrees of differential susceptibility to infection across the rheumatic diseases, which should be taken into account in weighing the infectious risks of biologics in the respective diseases.
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
A case of granulomatous mastitis with erythema nodosum and arthritis
Rheumatology International, 12/19/09
Better assessment of physical function: item improvement is neglected but essential
Arthritis Research & Therapy, 12/19/09
A case of juvenile idiopathic polyarticular arthritis complicated by IgA deficiency in 22q11 deletion syndrome
Rheumatology International, 12/19/09